Home | Free 30-Day Trial | Tutorial | Help
Medical Disability Advisor  >  Diabetes Mellitus Type II  >  Diagnosis

Diabetes Mellitus Type II


Related Terms


  • Adult Onset Diabetes Mellitus
  • NIDDM
  • Non-insulin Dependent Diabetes Mellitus
  • Nonketotic Diabetes Mellitus
  • T2DM
  • Type II Diabetes
  • Type II Diabetes Mellitus

Differential Diagnoses


Specialists


  • Cardiovascular Internist
  • Clinical Psychologist
  • Endocrinologist
  • Nephrologist
  • Neurologist
  • Ophthalmologist
  • Orthopedic (Orthopaedic) Surgeon
  • Urologist

Comorbid Conditions


Sign-in as a subscriber or take a free trial to see the renowned Reed Group physiological recovery durations in place of this advertising.

Factors Influencing Duration


Factors influencing the length of disability include the presence and progression of complications, infections, loss of vision, amputation of foot or leg, dialysis, individual compliance with self-care regimen, and response to treatment.

Duration Trends from Reference Data


DURATION TRENDS
 ICD-9-CM: 250.00, 250.02  
CasesMeanMinMaxNo Lost TimeOver 6 Months
10134401891.3%1.7%
 
  
 
Percentile:5th25thMedian75th95th
Days:6163158138
 
  
 

Differences may exist between the duration tables and the reference graphs. Duration tables provide expected recovery periods based on the type of work performed by the individual. The reference graphs reflect the actual experience of many individuals across the spectrum of physical conditions, in a variety of industries, and with varying levels of case management. Selected graphs combine multiple codes based on similar means and medians.

Medical Codes


ICD-9-CM:
250 - Diabetes Mellitus
250.0 - Diabetes Mellitus without Mention of Complication
250.00 - Diabetes Mellitus Type II
250.02 - Diabetes Mellitus without Mention of Complication; Type II or Unspecified Type, Uncontrolled
250.12 - Diabetes with Ketoacidosis; Diabetic: Acidosis without Mention of Coma, Ketosis without Mention of Coma; Type II or Unspecified Type, Uncontrolled
250.2 - Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma
250.20 - Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma; Type II or Unspecified Type, Not Stated as Uncontrolled
250.22 - Diabetes with Hyperosmolarity; Hyperosmolar (Nonketotic) Coma; Type II or Unspecified Type, Uncontrolled
250.3 - Diabetes with Other Coma
250.30 - Diabetes with Other Coma; Diabetic Coma (with Ketoacidosis), Diabetic Hypoglycemic Coma, Insulin Coma NOS; Type II or Unspecified Type, not Stated as Uncontrolled
250.32 - Diabetes with Other Coma; Diabetic Coma (with Ketoacidosis), Diabetic Hypoglycemic Coma, Insulin Coma NOS; Type II or Unspecified Type, Uncontrolled
250.4 - Diabetic Glomerulosclerosis
250.40 - Diabetes with Renal Manifestations; Type II or Unspecified Type, not Stated as Uncontrolled
250.42 - Diabetes with Renal Manifestations; Type II or Unspecified Type, Uncontrolled
250.5 - Diabetes with Ophthalmic Manifestations
250.50 - Diabetes with Ophthalmic Manifestations; Type II or Unspecified Type, not Stated as Uncontrolled
250.52 - Diabetes with Ophthalmic Manifestations; Type II or Unspecified Type, Uncontrolled
250.6 - Diabetes with Neurological Manifestations
250.60 - Diabetes with Neurological Manifestations; Type II or Unspecified Type, not Stated as Uncontrolled
250.62 - Diabetes with Neurological Manifestations; Type II or Unspecified Type, Uncontrolled
250.7 - Diabetic Gangrene
250.70 - Diabetes with Peripheral Circulatory Disorders; Type II or Unspecified Type, Not Stated as Uncontrolled
250.72 - Diabetes with Peripheral Circulatory Disorders; Type II or Unspecified Type, Uncontrolled
250.8 - Diabetes with Other Specified Manifestations
250.80 - Type II (Non-insulin Dependent Type) or Unspecified Type Diabetes Mellitus with Other Specified Manifestations, Not Stated as Uncontrolled
250.82 - Type II (Non-insulin Dependent Type) or Unspecified Type Diabetes Mellitus with Other Specified Manifestations, Uncontrolled
250.9 - Diabetes with Unspecified Complications
250.90 - Diabetes with Unspecified Complications; Type II or Unspecified Type, not Stated as Uncontrolled
250.92 - Diabetes with Unspecified Complications; Type II or Unspecified Type, Uncontrolled

History


History: Individuals often are asymptomatic and only occasionally report the classic symptoms of diabetes mellitus, including increased urination (polyuria), excessive thirst (polydipsia), and excessive hunger (polyphagia). The individual may complain of frequent skin infections that are slow to heal, itching, blurred vision, tingling, numbness, and pain in the arms and legs. There may be a feeling of general fatigue and drowsiness. Women may experience chronic vaginal infections (vaginitis).

Physical exam: High blood pressure is present in at least half the individuals with type 2 diabetes, and obesity is a very common finding. The feet and lower legs are examined carefully for signs of ulceration, persistent infection, or gout. Blood pressure in the leg may be lower than in the arm (ankle-brachial index) indicating poor circulation to the extremities. A decreased sensation of pain may be detected in the legs and feet consistent with peripheral nerve dysfunction (diabetic neuropathy). An eye exam may reveal changes in the blood vessels, bleeding, and yellow or white patches in the retina (diabetic retinopathy).

Tests: Diagnosis depends primarily on plasma glucose levels, especially an elevated level of fasting plasma glucose (FPG) and the presence of impaired glucose tolerance (IGT). Glucose tolerance testing measures and compares fasting and non-fasting blood glucose levels to evaluate glucose metabolism. The oral glucose tolerance test measures blood glucose at half-hour intervals within 2 hours after drinking a set amount of a glucose solution. Individuals with diabetes show abnormal rises in blood glucose (hyperglycemia) within the 2-hour period.

Urinalysis is performed to measure the amount of glucose excreted in the urine; elevated urine glucose (glycosuria) is a typical abnormal finding in diabetes. The absence of ketosis (abnormally elevated concentration of ketones in the blood) is a primary feature that distinguishes type 2 from type 1 diabetes. A blood chemistry profile is performed to evaluate lipid levels, fluid and electrolyte balance, and to measure serum creatinine, an indicator of kidney function. Periodic testing of the amount of glucose bound to a protein (hemoglobin) in red blood cells (glycosylated hemoglobin or HbA1c) may be used to estimate plasma glucose levels over the preceding 1 to 3 months, and may help the physician recommend changes in diet, exercise, and insulin therapy. However, lack of standardization of assays for HbA1c has discouraged physicians from using it for diagnosis even though it may be used to monitor effectiveness of treatment (Kronenberg).

Source: Medical Disability Advisor






Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to:
Sales Customer Support Content Development
 
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.